712 North Inc., a California-based pharmaceutical company, is pioneering personalized mitochondrial medicine for patients with complex diseases such as Alzheimer's dementia, heart failure, and cancer. Our unique approach combines mitochondrial biology with pharmaceutical drug development by targeting proteases within the mitochondrial inner membrane. These proteases represent highly promising drug targets with implications for numerous fatal disorders. Therefore, instead of relying solely on medical diagnosis, we believe profiling an individual's proteases is essential for selecting the most effective treatment. This personalized approach is central to 712 North's mission. By focusing on specific pathways rather than individual diseases, we are positioned to be first-in-class.
712 North Inc., a California-based pharmaceutical company, is pioneering personalized mitochondrial medicine for patients with complex diseases such as Alzheimer's dementia, heart failure, and cancer. Our unique approach combines mitochondrial biology with pharmaceutical drug development by targeting proteases within the mitochondrial inner membrane. These proteases represent highly promising drug targets with implications for numerous fatal disorders. Therefore, instead of relying solely on medical diagnosis, we believe profiling an individual's proteases is essential for selecting the most effective treatment. This personalized approach is central to 712 North's mission. By focusing on specific pathways rather than individual diseases, we are positioned to be first-in-class.
Our screening platform
Our screening platform
712 North at BIO Investor Forum 2019
712 North at BIO Investor Forum 2019
Follow us on X
Follow us on X
Like us on facebook
Like us on facebook
Connect with us on LinkedIn
Connect with us on LinkedIn
Write us an e-mail
Write us an e-mail
Chat with us on WeChat
Chat with us on WeChat
